[
{"label":"Best Practice NZ. Safer prescribing of high-risk medicines - Methotrexate: potentially fatal in overdose. <i>Best Practice Journal. 2014; 64.</i>","link":"http://www.bpac.org.nz/BPJ/2014/October/safer-prescribing.aspx"},
{"label":"2 Roughead EE, Semple SJ, Rosenfeld E. The extent of medication errors and adverse drug reactions throughout the patient journey in acute care in Australia <i>Int J Evid Based Healthc</i>. 2016 Sep;14(3):113-22. doi: 10.1097/XEB.0000000000000075.","link":"https://www.ncbi.nlm.nih.gov/pubmed/26886682"},
{"label":"Medical Board of Australia. <i>Good medical practice: a code of conduct for doctors in Australia. 2020.</i>","link":"http://www.medicalboard.gov.au/Codes-Guidelines-Policies/Code-of-conduct.aspx"},
{"label":"Antibiotic Expert Groups. <i>Therapeutic Guidelines, Antibiotic</i>. Version 16, West Melbourne: Therapeutic Guidelines Ltd, 2019.","link":"https://tgldcdp.tg.org.au/index"},
{"label":"Kalish LM, Caughey GE, Roughead EE, et al. The prescribing cascade. <i>Australian Prescriber</i> 2011;34:162-6.","link":"https://www.nps.org.au/australian-prescriber/articles/the-prescribing-cascade"},
{"label":"de Vries TPGM, Henning RH, Hogerzeil HV, et al. Guide to Good Prescribing. A practical manual. World Health Organization Action Programme on Essential Drugs, 1994.","link":"http://apps.who.int/medicinedocs/pdf/whozip23e/whozip23e.pdf"},
{"label":"Gazarian M, Kelly M, McPhee JR, et al. Off-label use of medicines: consensus recommendations for evaluating appropriateness. Med J Aust 2006;185:544-8.","link":"https://www.ncbi.nlm.nih.gov/pubmed/17115966"},
{"label":"Astra Zeneca Pty Ltd. BRILINTA (ticagrelor) Product Information. 2014.","link":"https://www.astrazeneca.com.au/content/dam/az-au/Material%20Safety%20Data/Brilintaltsupgt174ltsupgt.pdf"},
{"label":"Day R. Off-label prescribing. Australian Prescriber 2013;36:182-3.","link":"https://www.nps.org.au/australian-prescriber/articles/off-label-prescribing"},
{"label":"Council of Australian Therapeutic Advisory Groups (CATAG). “Rethinking medicines decision-making in Australian Hospital”. Guiding Principles for the quality use of off-label medicines (2013)","link":"http://www.catag.org.au/wp-content/uploads/2012/08/OKA9963-CATAG-Rethinking-Medicines-Decision-Making-final1.pdf"}
]
